The classification screen

4 questions before you choose the route.

This page identifies the right question and evidence. It does not determine the legal outcome on a reader’s facts.

01

Where does the claim appear?

Pack/site/live.

Place
02

Absolute terms or efficacy promises?

Risk words.

Words
03

Sector overlay (device/pharma/food)?

Extra rules.

Sector
04

KOL involved?

Resolve the kol involved question separately before choosing the route.

KOL

Working rule: China’s Advertising Law prohibits false or misleading advertising and tightly restricts absolute terms and certain endorsements.

What changes the answer

The signal ledger.

These facts move the question beyond a label and into a product, money-flow and control analysis.

Signal
Ask the operating question
Why it changes the route
Broader Product Liability analysis needed
Do the facts extend beyond the threshold Advertising Law in China question?
Additional facts can change the Product Liability route, evidence and next step.
Translator ‘best-in-class’ leftover
Absolute term.
Edit.
Ignore live medical-device advertising rules
Sector miss.
Sector pages.
Prepare before you escalate

Bring a compact evidence docket—not a pitch deck.

Give a compliance team or counsel the operating facts that reveal the perimeter.

01Claim inventoryWhat was said.
02Approvals for restricted adsIf any.
03Takedown noticesEnforcement.
Common confusions

Questions people ask before they build.

Short answers for orientation. The right result can change with the service model and current rules.

Are overseas websites exempt?

Targeting China consumers still creates risk. Do not assume.com is invisible.

Where is influencer detail?

Use the linked specialist resource when Advertising Law in China turns on detailed evidence, procedure or risk assessment.

Primary authorities

Reviewed sources support orientation, not a fact-specific assessment.

SAMR
National laws database (NPC)
NMPA (devices/cosmetics where relevant)
General Administration of Customs (GACC)